Last reviewed · How we verify
Chronic lymphocyticleukemia/small lymphocytic lymphoma
Approved treatments
- Calquence · AstraZeneca
Calquence works by blocking the activity of the BTK enzyme, which is essential for the activation and survival of B cells. - Calquence · iOMEDICO AG
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic lymphocyticleukemia/small lymphocytic lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Chronic lymphocyticleukemia/small lymphocytic lymphoma treatment landscape brief
- Chronic lymphocyticleukemia/small lymphocytic lymphoma treatment updates RSS
Frequently asked questions about Chronic lymphocyticleukemia/small lymphocytic lymphoma
What drugs treat Chronic lymphocyticleukemia/small lymphocytic lymphoma?
Tracked treatments include Calquence.
What is the treatment for Chronic lymphocyticleukemia/small lymphocytic lymphoma?
Standard treatment for Chronic lymphocyticleukemia/small lymphocytic lymphoma includes Calquence. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic lymphocyticleukemia/small lymphocytic lymphoma patent cliff · Chronic lymphocyticleukemia/small lymphocytic lymphoma CI report
- Treatment: Calquence · AstraZeneca
- Treatment: Calquence · iOMEDICO AG
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing